Multi-omic biomarker approaches for Target-Disease Link

Session Chair - Funded(s)

• EA

  Elnaz Atabakhsh, PhD

  Associate Director - Scientific Alliances and Collaborations
  Repertoire Immune Medicines, Massachusetts, United States

Session Chair(s)

• 

  Catherine Tralau-Stewart, PhD

  Senior Director Alliances
  Takeda Pharmaceuticals, California, United States

Presentations:

• 4:00 PM – 4:30 PM

  Coordinated automation to support biomarker discovery using machine learning
  

  Kevin M. Elias, MD – Brigham and Women's Hospital
• 4:30 PM – 5:00 PM

  Enabling the Field: A Strategic Perspective on Molecular Insight
  

  Bradford Casey, PhD – The Michael J Fox Foundation
• 5:00 PM – 5:30 PM

  Multi-Omics analysis mapping fibrotic changes in Bleomycin-induced pulmonary fibrosis in young and old mice
  

  Daniel Veyel, PhD – Boehringer Ingelheim Pharma GmbH & Co. KG